ASHIRA LASDUN: Open Payments
NPI 1467727008 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,637 in 47 payments from 15 companies in 2025. Trend: 2023 $680 · 2024 $739 · 2025 $1,637
Food & beverage: $1,527Education: $109
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $279 |
| Teva Pharmaceuticals USA, Inc. | 6 | $186 |
| Tris Pharma Inc | 12 | $175 |
| Janssen Pharmaceuticals, Inc | 4 | $174 |
| ABBVIE INC. | 7 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Biogen, Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
Products named: LYBALVI, VRAYLAR, CAPLYTA, Qelbree, SPRAVATO, ZURZUVAE, Sunosi, Onyda XR.
Industry payments across NJ — which companies pay providers there.
